Downregulation of ZIP kinase is associated with tumor invasion, metastasis and poor prognosis in gastric cancer

International Journal of Cancer

Volumn 124, Issue 7, 2009, Pages 1587-1593

  Bi, Jiong ^a   Lau, Sze Hang ^b   Hu, Liang ^b   Rao, Hui Lan ^a   Liu, Hai Bo ^c   Zhan, Wen Hua ^a   Chen, Gong ^a   Wen, Jian Ming ^a   Wang, Qian ^a   Li, Bin ^a   Guan, Xin Yuan ^b,c  

^a SUN YAT SEN UNIVERSITY   (China)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

19p13.3; Array CGH; Gastric carcinoma; Prognosis; ZIPK

Indexed keywords

DEATH ASSOCIATED PROTEIN KINASE; KINASE ZIP; UNCLASSIFIED DRUG; APOPTOSIS REGULATORY PROTEIN; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE; DEATH-ASSOCIATED PROTEIN KINASE; TUMOR MARKER;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER INVASION; CHROMOSOME 13; CHROMOSOME 16Q; CHROMOSOME 19; CHROMOSOME 3; CHROMOSOME 5P; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENE IDENTIFICATION; GENE LOSS; GENE NUMBER; GENETIC GAIN; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; METASTASIS; NICK END LABELING; PRIORITY JOURNAL; PROGNOSIS; STOMACH CARCINOMA; TISSUE MICROARRAY; ENZYMOLOGY; GENETICS; KAPLAN MEIER METHOD; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; STOMACH TUMOR;

ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASES; COMPARATIVE GENOMIC HYBRIDIZATION; DOWN-REGULATION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PROGNOSIS; STOMACH NEOPLASMS; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 61449096746     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.24164     Document Type: Article

References (42)

1. Ferlay J, Bray F, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
2. Yang L. Incidence and mortality of gastric cancer in China. World J Gastroenterol 2006;12:17-20.
3. Tsugane S, Sasazuki S. Diet and the risk of gastric cancer: review of epidemiological evidence. Gastric Cancer 2007;10:75-83.
4. Sakakura C, Mori T, Sakabe T, Ariyama Y, Shinomiya T, Date K, Hagiwara A, Yamaguchi T, Takahashi T, Nakamura Y, Abe T, Inazawa J. Gains, losses, and amplifications of genomic materials in primary gastric cancers analyzed by comparative genomic hybridization. Genes Chromosomes Cancer 1999;24:299-305.
5. van Grieken NC, Weiss MM, Meijer GA, Hermsen MA, Scholte GH, Lindeman J, Craanen ME, Bloemena E, Meuwissen SG, Baak JP, Kuipers EJ. Helicobacter pylori-related and -non-related gastric cancers do not differ with respect to chromosomal aberrations. J Pathol 2000;192:301-6.
6. Guan XY, Fu SB, Xia JC, Fang Y, Sham JS, Du BD, Zhou H, Lu S, Wang BQ, Lin YZ, Liang Q, Li XM, et al. Recurrent chromosome changes in 62 primary gastric carcinomas detected by comparative genomic hybridization. Cancer Genet Cytogenet 2000;123:27-34.
7. Noguchi T, Wirtz HC, Michaelis S, Gabbert HE, Mueller W. Chromosomal imbalances in gastric cancer: correlation with histologic subtypes and tumor progression. Am J Clin Pathol 2001;115:828-34.
8. Kimura Y, Noguchi T, Kawahara K, Daa T, Yokoyama S. Genetic alterations in 102 primary gastric cancers by comparative genomic hybridization: gain of 20q and loss of 18q are associated with tumor progression. Mod Pathol 2004;17:1328-37.
9. Solinas-Toldo S, Lampel S, Stilgenbauer S, Nickolenko J, Benner A, Dohner H, Cremer T, Lichter P. Matrix-based comparative genomic hybridization: biochips to screen for genomic imbalances. Genes Chromosomes Cancer 1997;20:399-407.
10. Pinkel D, Segraves R, Sudar D, Clark S, Poole I, Collins C, Kuo WL, Zhai Y, Dairkee SH, Ljung BM, Gray JW, Albertson DG. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat Genet 1998;20:207-11.
11. Pinkel D, Albertson DG. Array comparative genomic hybridization and its applications in cancer. Nat Genet 2005;37(Suppl):S11-7.
12. Graves PR, Winkfield KM, Haystead TA. Regulation of zipper-interacting protein kinase activity in vitro and in vivo by multisite phosphorylation. J Biol Chem 2005;280:9363-74.
13. World Health Organization (WHO). Tumours of the stomach. In: Hamilton SR, Aaltonen LA, eds. World Health Organization classification of tumours. Tumours of the digestive system. Lyon: IARC Press, 2000, 37-68.
14. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma-2nd English edition. Gastric Cancer 1998;1:10-24.
15. UICC. In: Sobin LH, Wittekind C, eds. TNM classification of malignant tumours, 6th edn. New York: Wiley-Liss, 2002.
16. Hu L, Lau SH, Tzang CH, Wen JM, Wang W, Xie D, Huang M, Wang Y, Wu MC, Huang JF, Zeng WF, Sham JS, et al. Association of Vimentin overexpression and hepatocellular carcinoma metastasis. Oncogene 2004;23:298-302.
17. Wang Y, Wu MC, Sham JST, Zhang W, Wu WQ, Guan XY. Different expression of hepatitis B surface antigen between hepatocellular carcinoma and its surrounding liver tissue detected by tissue microarray. J Pathol 2002;197:610-6.
18. Kawai T, Matsumoto M, Takeda K, Sanjo H, Akira S. ZIP kinase, a novel serine/threonine kinase which mediates apoptosis. Mol Cell Biol 1998;18:1642-51.
19. Weber KL, Sokac AM, Berg JS, Cheney RE, Bement WM. A micro-tubule-binding myosin required for nuclear anchoring and spindle assembly. Nature 2004;431:325-9.
20. Xie D, Ma NF, Pan ZZ, Wu HX, Liu YD, Wu GQ, Kung HF, Guan XY. Overexpression of EIF-5A2 is associated with metastasis of human colorectal carcinoma. Hum Pathol 2008;39:80-5.
21. Kimmel RR, Zhao LP, Nguyen D, Lee S, Aronszajn M, Cheng C, Troshin VP, Abrosimov A, Delrow J, Tuttle RM, Tsyb AF, Kopecky KJ, et al. Microarray comparative genomic hybridization reveals genome-wide patterns of DNA gains and losses in post-Chernobyl thyroid cancer. Radiat Res 2006;166:519-31.
22. Lu Y, Lemon W, Liu PY, Yi Y, Morrison C, Yang P, Sun Z, Szoke J, Gerald WL, Watson M, Govindan R, You M. A gene expression signature predicts survival of patients with stage I non-small cell lung cancer. PLoS Med 2006;3:e467.
23. Arvidsson Y, Andersson E, Bergstrom A, Andersson MK, Altiparmak G, Illerskog AC, Ahlman H, Lamazhapova D, Nilsson O. Amyloid precursor-like protein 1 is differentially upregulated in neuroendocrine tumours of the gastrointestinal tract. Endocr Relat Cancer 2008;15:569-81.
24. Wikman H, Ruosaari S, Nymark P, Saharinen J, Vanhala E, Karjalainen A, Hollmen J, Knuutila S, Anttila S. Gene expression and copy number profiling suggests the importance of allelic imbalance in 19p in asbestos-associated lung cancer. Oncogene 2007;26:4730-7.
25. Kowalski J, Morsberger LA, Blackford A, Hawkins A, Yeo CJ, Hruban RH, Griffin CA. Chromosomal abnormalities of adenocarcinoma of the pancreas: identifying early and late changes. Cancer Genet Cytogenet 2007;178:26-35.
26. Miyai K, Furugen Y, Matsumoto T, Iwabuchi K, Hirose S, Kinoshita K, Fujii H. Loss of heterozygosity analysis in uterine cervical adenocarcinoma. Gynecol Oncol 2004;94:115-20.
27. Yanaihara N, Okamoto A, Matsufuji S. A commonly deleted region in ovarian cancer on chromosome 19p13.3, not including the OAZ1 gene. Int J Oncol 2003;23:567-75.
28. Fu Y, Zagozdzon R, Avraham R, Avraham HK. CHK negatively regulates Lyn kinase and suppresses pancreatic cancer cell invasion. Int J Oncol 2006;29:1453-8.
29. Bialik S, Kimchi A. The death-associated protein kinases: structure, function, and beyond. Annu Rev Biochem 2006;75:189-210.
30. Deiss LP, Feinstein E, Berissi H, Cohen O, Kimchi A. Identification of a novel serine/threonine kinase and a novel 15-KD protein as potential mediators of the gamma interferon-induce cell death. Genes Dev 1995;9:15-30.
31. Cohen O, Inbal B, Kissil JL, Raveh T, Berissi H, Spivak-Kroizaman T, Feinstein E, Kimchi A. DAP-kinase participates in TNF-alpha and Fas-induced apoptosis and its function requires the death domain. J Cell Biol 1999;146:141-8.
32. Jang CW, Chen CH, Chen CC, Chen JY, Su YH, Chen RH. TGF-beta induces apoptosis through Smad-mediated expression of DAP-kinase. Nat Cell Biol2001;10:10.
33. Inbal B, Cohen O, Polak-Charcon S, Kopolovic J, Vadai E, Eisenbach L, Kimchi A. DAP kinase links the control of apoptosis to metastasis. Nature 1997;390:180-4.
34. Kawai T, Akira S, Reed JC. ZIP kinase triggers apoptosis from nuclear PML oncogenic domains. Mol Cell Biol 2003;23:6174-86.
35. Vetterkind S, Illenberger S, Kubicek J, Boosen M, Appel S, Naim HY, Scheidtmann KH, Preuss U. Binding of par-4 to the action cyto-skeleton is essential for par-4/DIK-mediated apoptosis. Exp Cell Res 2005;305:392-408.
36. Kogel D, Bierbaum H, Preuss U, Scheidtmann KH. C-terminal truncation of Dlk/ZIP kinase leads to abrogation of nuclear transport and high apoptotic activity. Oncogene 1999;18:7212-8.
37. Kogel D, Reimertz C, Dussmann H, Mech P, Scheidtmann KH, Prehn JH. The death associated protein (DAP) kinase homologue Dlk/ZIP kinase induces p19ARF- and p53-independent apoptosis. Eur J Cancer 2003;39:249-56.
38. Murata-Hori M, Fukuta Y, Ueda K, Iwasaki T, Hosoya H. HeLa ZIP kinase induces diphosphorylation of myosin II regulatory light chain and reorganization of actin filaments in nonmuscle cells. Oncogene 2001;20:8175-83.
39. Shoval Y, Pietrokovski S, Kimchi A. ZIPK: a unique case of murine-specific divergence of a conserved vertebrate gene. PLoS Genet 2007;3:1884-93.
40. Dansranjavin T, Moobius C, Tannapfel A, Bartels M, Wittekind C, Hauss J, Witzigmann H. E-cadherin and DAP kinase in pancreatic adenocarcinoma and corresponding lymph node metastases. Oncol Rep 2006;15:1125-31.
41. Martinez-Glez V, Franco-Hemandez C, Gonzalez-Gomez P, Isla A, De Campos JM, Vaguero J, Gutierrez M, Gasartelli C, Rey JA. DAPK1 promoter hypermethylaiton in brain metastases and peripheral blood. Neoplasma 2007;54:123-6.
42. Kuo JC, Wang WJ, Yao CC, Wu PR, Chen RH. The tumor suppressor DAPK inhibits cell motility by blocking the integrin-mediated polarity pathway. J Cell Biol 2006;172:619-31.